AHF has filed legal action to challenge the validity of the Florida Department Of Health’s late-night trickery adopting a new emergency rule to cut off funding AHF has filed legal action to challenge the validity of the Florida Department Of Health’s late-night trickery adopting a new emergency rule to cut off funding

AHF Sues Florida to Block Fake Emergency Rule that Cuts AIDS Drugs to 16,000

2026/02/27 02:01
3 min read

AHF has filed legal action to challenge the validity of the Florida Department Of Health’s late-night trickery adopting a new emergency rule to cut off funding and access to lifesaving HIV medications for thousands of Floridians on March 1

NOTE: AHF Leadership is available for interviews

TALLAHASSEE, Fla.–(BUSINESS WIRE)–This morning AIDS Healthcare Foundation (AHF) filed an administrative action to challenge the validity of the emergency rule enacted by the Florida Department of Health, prior to a hearing scheduled yesterday morning with State Administrative Law Judge W. David Watkins. The Florida Department of Health has invoked emergency powers designed to protect public health in order to cut 16,000 Floridians off their HIV medications.

On the eve of a court hearing challenging its unlawful cuts to the AIDS Drug Assistance Program (ADAP), the Department filed an emergency rule slashing eligibility by more than two-thirds, eliminating health insurance premium assistance entirely, and terminating currently enrolled patients effective March 1. The agency tasked with protecting Floridians from communicable disease declared an emergency so it could stop treating them.

“We will not relent in fighting these heartless actions legally. AHF has always put our clients and those living with HIV/AIDS at the center of our mission,” said Michael Weinstein, President of AHF. “The Department of Health needs to stop all this trickery and stay focused on ensuring the sustained health and well-being of all Floridians.”

Separately, the Department has removed Biktarvy, the most widely prescribed HIV medication in the country, from the ADAP formulary without any rulemaking or public notice. For patients who have spent years achieving undetectable viral loads, forced medication switching risks irreversible drug resistance that no future funding or court order can undo.

The emergency rule expires in 90 days. Bipartisan majorities in both chambers of the Florida Legislature have proposed bridge funding to maintain ADAP coverage, including a Senate proposal that would preserve the 400% FPL eligibility threshold. But legislative appropriations cannot take effect before July 1, the start of the state fiscal year. That leaves a gap of at least four months where 16,000 Floridians have no coverage, no funding mechanism, and no public explanation from the Department of how they are supposed to maintain access to their medications.

No AHF patient will go without medication. We will use every resource at our disposal to keep our patients on their medications while we fight on.

AHF will fight in court. We will immediately seek injunctive relief to stop the Department from stripping life-saving coverage from thousands of Floridians. We will not relent.

In Florida, an emergency rule like DOH’s is only in effect for 90 days and is non-renewable.

Contacts

Media Contacts:
W. Imara Canady, National Director, Communications & Community Engagement, AHF
Cell: 770-940-6555/Email: imara.canady@ahf.org

Market Opportunity
Blockstreet Logo
Blockstreet Price(BLOCK)
$0.005976
$0.005976$0.005976
-0.11%
USD
Blockstreet (BLOCK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Which Altcoins Stand to Gain from the SEC’s New ETF Listing Standards?

Which Altcoins Stand to Gain from the SEC’s New ETF Listing Standards?

On Wednesday, the US SEC (Securities and Exchange Commission) took a landmark step in crypto regulation, approving generic listing standards for spot crypto ETFs (exchange-traded funds). This new framework eliminates the case-by-case 19b-4 approval process, streamlining the path for multiple digital asset ETFs to enter the market in the coming weeks. Grayscale’s Multi-Crypto Milestone Grayscale secured a first-mover advantage as its Digital Large Cap Fund (GDLC) received approval under the new listing standards. Products that will be traded under the ticker GDLC include Bitcoin, Ethereum, XRP, Solana, and Cardano. “Grayscale Digital Large Cap Fund $GDLC was just approved for trading along with the Generic Listing Standards. The Grayscale team is working expeditiously to bring the FIRST multi-crypto asset ETP to market with Bitcoin, Ethereum, XRP, Solana, and Cardano,” wrote Grayscale CEO Peter Mintzberg. The approval marks the US’s first diversified, multi-crypto ETP, signaling a shift toward broader portfolio products rather than single-asset ETFs. Bloomberg’s Eric Balchunas explained that around 12–15 cryptocurrencies now qualify for spot ETF consideration. However, this is contingent on the altcoins having established futures trading on Coinbase Derivatives for at least six months. This includes well-known altcoins like Dogecoin (DOGE), Litecoin (LTC), and Chainlink (LINK), alongside the majors already included in Grayscale’s GDLC. Altcoins in the Spotlight Amid New Era of ETF Eligibility Several assets have already met the key condition, regulated futures trading on Coinbase. For example, Solana futures launched in February 2024, making the token eligible as of August 19. “The SEC approved generic ETF listing standards. Assets with a regulated futures contract trading for 6 months qualify for a spot ETF. Solana met this criterion on Aug 19, 6 months after SOL futures launched on Coinbase Derivatives,” SolanaFloor indicated. Crypto investors and communities also identified which tokens stand to gain. Chainlink community liaison Zach Rynes highlighted that LINK could soon see its own ETF. He noted that both Bitwise and Grayscale have already filed applications. Meanwhile, the Litecoin Foundation indicated that the new standards provide the regulatory framework for LTC to be listed on US exchanges. Hedera is also in the spotlight, with digital asset investor Mark anticipating an HBAR ETF. Market observers see the decision as a potential turning point for broader adoption, bringing the much-needed clarity and accessibility for investors. At the same time, it boosts confidence in the market’s maturity. The general sentiment is that with the SEC’s approval, the next phase of crypto ETFs is no longer a question of ‘if,’ but ‘when.’ The shift to generic listing standards could expand the US-listed digital asset ETFs roster beyond Bitcoin and Ethereum. Such a move would usher in new investment vehicles covering a dozen or more altcoins. This represents the clearest path yet toward mainstream, regulated access to diversified crypto exposure. More importantly, it comes without the friction of direct custody. “We’re gonna be off to the races in a matter of weeks,” ETF analyst James Seyffart quipped.
Share
Coinstats2025/09/18 12:57
Telegram Turns DeFi With New Yield Options for BTC and ETH

Telegram Turns DeFi With New Yield Options for BTC and ETH

The post Telegram Turns DeFi With New Yield Options for BTC and ETH appeared on BitcoinEthereumNews.com. The yield feature is powered by DeFi protocols like Morpho
Share
BitcoinEthereumNews2026/02/27 05:17
Shiba Inu Price Struggles Below 26-Day EMA — Is a Breakdown or Breakout Next?

Shiba Inu Price Struggles Below 26-Day EMA — Is a Breakdown or Breakout Next?

Shiba Inu is once again testing a familiar ceiling. The 26-day exponential moving average (EMA) remains dynamic resistance, blocking what has been a fragile recovery
Share
Coinstats2026/02/27 04:39